Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-𝛽1) in Patients with Gastric Cancer

Table 5

TGF-𝛽1 serum levels in patients with H. pylori-positive and H. pylori-negative gastric carcinomas.

Examined group	No. of patients	No. (%) of cases with TGF-𝛽1 serum level		𝑃-value for difference
		normal	increased
H. pylori-positive gastric carcinomas	15	4 (26.7%)	11 (73.3%)	1.0000
H. pylori-negative gastric carcinomas	27	6 (22.2%)	21 (77.8%)